Latest Breaking News On - Marketwatch victor reklaitis - Page 1 : comparemela.com

US Hits $34 Trillion in Debt

Happy Tuesday and happy new year! We’re back, but Congress doesn’t return until next week and President Joe Biden is just heading home to the White House from his “working vacation” in St. Croix tonight, so let’s ease into the new year by looking ahead to what awaits lawmakers in the first weeks of 2024: a hugely consequential fight over government funding.

House approves Biden's $2 trillion social-spending bill — but big changes loom in Senate

House approves Biden's $2 trillion social-spending bill — but big changes loom in Senate

Convicted Mueller witness dropped $4M on unsuccessful commutation lobbying

POLITICO Get the POLITICO Influence newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Coalition for App Fairness With Daniel Lippman and Theodoric Meyer CONVICTED MUELLER WITNESS DROPPED $4M ON CLEMENCY LOBBYING: One filing that caught PI’s eye this week was the reported $4 million that Robert Stryk’s ZAMZAM on behalf of

Global COVID-19 case tally above 134 million as more countries impose restrictions on AstraZeneca vaccine

Global COVID-19 case tally above 134 million as more countries impose restrictions on AstraZeneca vaccine MarketWatch 2 hrs ago CORONAVIRUS UPDATE The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed above 134 million on Friday and the death toll edged closer to 3 million, as controversy continued to swirl around the vaccine developed by AstraZeneca PLC and Oxford University that one regulator said could cause blood clots in very rare instances. Popular Searches The European Medicines Agency said this week that an investigation found a link between the vaccine and blood-clotting incidents in a very small number of cases involving mostly European recipients. But the EMA said the benefits of the vaccine, which has become the most widely used in Europe, continue to outweigh the risks.